Resolute Advisors LLC Invitae Corp Transaction History

Resolute Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$2.13 - $9.01 $2,245 - $9,496	-1,054 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $2,431 - $3,360	-100 Reduced 8.67%	1,054 $30,000
Q2 2021 Dec 27, 2021	BUY	$26.09 - $40.4 $30,107 - $46,621	1,154 New	1,154 $39,000
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $30,107 - $46,621	-1,154 Closed	0 $0
Q1 2021 Dec 27, 2021	BUY	$33.06 - $56.93 $38,151 - $65,697	1,154 New	1,154 $44,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.